Industry domain
Healthcare & Life Sciences
Hospitals, pharmaceuticals and digital health — licensing, clinical governance and patient data.
Industry Context
Healthcare and pharmaceuticals sit under the Drugs and Cosmetics Act, 1940 and its rules, the New Drugs and Clinical Trials Rules, and state clinical establishment legislation, with the Central Drugs Standard Control Organisation and state drug controllers sharing oversight. Manufacturing, import, clinical trial approval, labelling and price control under the Drugs (Prices Control) Order each have their own compliance track.
Service delivery adds a further layer: clinical establishment registration, biomedical waste authorisation, radiation safety approvals, PCPNDT compliance for diagnostic imaging, and professional regulation of practitioners. Digital health has brought telemedicine practice guidelines and, with the DPDP Act, express treatment of health data as a category demanding heightened care.
Transaction Patterns
Consolidation drives much of the corporate work — hospital and diagnostic chain acquisitions, single-speciality roll-ups, and private equity investment into platforms — where diligence has to cover licensing, clinical governance and medical negligence exposure alongside the usual corporate ground.
Operationally, the sector generates a continuous stream of contracting (doctor engagement, referral and revenue sharing arrangements that have to stay within professional conduct rules, equipment supply and service, clinical trial and CRO agreements) and of disputes (consumer commission negligence claims, drug price control demands, and regulatory action against establishments).
Common cases in this domain
Licensing and Establishment Compliance
Clinical establishment registration, drug manufacturing and sale licences, import registration, blood bank and radiation approvals, biomedical waste authorisation, PCPNDT registration, and fire and building compliance for hospital premises.
Pharmaceutical Regulatory
New drug and clinical trial approvals, CDSCO interaction, labelling and packaging requirements, price control under the DPCO and NPPA compliance, marketing practice codes, and recall and pharmacovigilance obligations.
Healthcare M&A and Investment
Hospital, diagnostic and single-speciality acquisitions, private equity investment into healthcare platforms, diligence on licences, clinical governance and negligence exposure, and structuring around restrictions on the corporate practice of medicine.
Clinical and Commercial Contracting
Doctor engagement and consultancy arrangements, referral and revenue sharing structures within professional conduct rules, equipment supply and service contracts, clinical trial and CRO agreements, informed consent documentation, and hospital-insurer empanelment.
Patient Data and Digital Health
DPDP compliance for health data, consent and notice design for clinical contexts, telemedicine practice guideline compliance, health record retention and access, ABDM participation, and data sharing with insurers and researchers.
Medical Negligence and Regulatory Disputes
Defence of consumer commission and civil negligence claims, professional council proceedings against practitioners, NPPA overcharging demands, and writ petitions against licensing or closure action.
Representative Work
Factual descriptions of the kind of work handled in this sector. Client names and identifying details are omitted, and nothing here is a representation about the outcome of any case.
- Acted for a private equity fund on a growth investment into a South India healthcare services platform.
- Advised a healthcare group on principal employer obligations and contractor documentation across three states.
- Constituted Internal Committees and delivered POSH training for a multi-location healthcare operator.
- Advised a diagnostic chain on patient data handling and consent design under the DPDP framework.
- Advised a pharmaceutical manufacturer's lenders on the security package for a rupee term facility.
- Advised on doctor engagement and revenue sharing documentation consistent with professional conduct requirements.
Regulators and Forums
The authorities, tribunals and courts that cases in this sector most often involve.
- Central Drugs Standard Control Organisation; state drug controllers
- National Pharmaceutical Pricing Authority
- State health departments and clinical establishment registering authorities
- National Medical Commission and state medical councils
- State Pollution Control Boards (biomedical waste); AERB (radiation safety)
- Data Protection Board of India; Consumer Disputes Redressal Commissions
Related Insights
We have not yet published an insight for this domain. Browse all insights.
Frequently Asked Questions
General information about legal issues in this sector. It is not legal advice and does not create a lawyer–client relationship.
What does healthcare diligence cover beyond the usual corporate review?
Licence and registration status for every location and every regulated activity, biomedical waste and radiation compliance, PCPNDT records where imaging is offered, the clinical governance framework, pending and threatened negligence claims and their reserving, doctor engagement terms and whether revenue sharing arrangements are compliant, and insurer empanelment terms. Licensing gaps are common and are frequently conditions precedent.
How does the DPDP Act affect patient records?
Health data is personal data and its sensitivity raises the practical standard for notice, consent, security safeguards and breach response, even though the Act does not create a separate special-category regime the way some other laws do. The harder questions in practice are retention, access by insurers and group entities, and research use — each of which needs to be within the purpose notified at collection.
Are doctor revenue sharing arrangements permitted?
Engagement of practitioners on a fee or revenue-linked basis is common and workable, but professional conduct regulations restrict fee splitting and payment for referrals. The distinction between compensating a doctor for services rendered and paying for a referral is the line that matters, and it turns on how the arrangement is structured and documented rather than on what it is called.
We received an NPPA overcharging demand. What are the options?
Verify the ceiling price applicable in the relevant period and the basis of the computation, since demands frequently rest on disputed assumptions about the formulation, pack size or period. Then consider representation before the authority and, where the demand is jurisdictionally or procedurally flawed, a writ petition. Interest accrues, so the timeline for responding matters.
Related services
Practice areas that serve this domain
Corporate Advisory
Acquisitions, investments, joint ventures and reorganisations — structured for the regulatory reality they have to survive.
Labour & Employment
Workforce structuring, the new labour codes, industrial relations and the disputes that follow termination.
Intellectual Property
Trade marks, copyright, designs and trade secrets — protection, commercialisation and enforcement.
Litigation
Civil and commercial litigation, company and insolvency proceedings, writs and appeals, before the courts and tribunals of South India.
ADR
Arbitration, mediation and conciliation, and the interim relief that often shapes settlement long before a hearing.